Inclusion Criteria:  Signed written informed consent. Male or female ≥ 18 years Having wounds (both chronic or acute wounds regardless of etiology), with the following characteristics: Non infected Wound Bed Score ≥4 and <13 Wound area ≤ 100 cm2 Patient having one or more factors associated with increased risk of wound infection (IWII, 2016) Patient able to read and understand the language and content of the study material, understand the requirements for follow-up visits, is willing to provide information at the scheduled evaluations and is willing, able and ensuring to comply with the study requirements for the whole study period.  Exclusion Criteria:  Absence of factors associated with increased risk of wound infection Infected wounds - where infection is defined by:  For chronic wounds:  A combination of three or more signs or symptoms of local infection: periwound skin erythema, local heat, persistent pain, oedema of wound.s edge, malodour, pus and heavy exudation (Cutting KF, 1994; Trial C, 2010);  For acute wounds:  Cellulitis or pus or abscess, Delayed healing, erythema, hardening of edge, serous-purulent drainage, malodour  Non-vital tissue greater than 25% of the total wound area Heavily exuding wounds Presence of fistula History of connective tissue disease, e.g., systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome or mixed connective tissue disease Active malignant disease Active sickle cell disease radiation therapy Known allergy to any of the devices' constituents Pregnant and breastfeeding women Subjects unable to understand informed consent or having a high probability of non- compliance with the study procedures and or non-completion of the study according to investigator's judgement.